Safety first: should the high tolerability of intramuscular anti-spike COVID-19 monoclonal antibody change our expectations of vaccine safety?

Putrino D., Curtis A., Leston M., Yalcin I., Gerlach R., Elia M., Mina M.

DOI

10.64898/2026.05.08.26352596

Type

Preprint

Publication Date

2026-05-08T00:00:00+00:00

Permalink More information Close